JAMA:omega-3脂肪酸对正在接受他汀治疗的心血管高危患者无显著临床收益

2020-11-17 MedSci原创 MedSci原创

对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件

长期以来omega-3脂肪酸(omega-3 CA),如二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)一直被认为对血管疾病风险有益,但其尚未得到大规模临床试验的证实,近日研究人员考察了一种含有EPA和DHA的制剂对动脉粥样硬化性血脂异常和心血管高危患者脂质和炎症标志物的影响。
 
本次双盲、随机、多中心试验在北美、欧洲、南美洲、亚洲、澳大利亚、新西兰和南非22个国家的675个医疗中心开展,研究人员考察了omega-3 CA对高心血管风险、高甘油三酯血症和高密度脂蛋白胆固醇(HDL-C)低水平人群的影响,参与者接受他汀类药物治疗,总计13078名患者,随机接受4g/d的omega-3 CA (n=6539)或玉米油 (对照组,n=6539)。研究的主要疗效指标包括心血管死亡、非致命性心肌梗死、非致命性中风、冠状动脉血运重建或需要住院治疗的不稳定心绞痛。
 
中期分析时,总计1384名患者发生主要终点事件,研究提前中止。研究结果表明omega-3-CA与玉米油相比,使患者获得临床受益的可能性很低。参与者平均年龄62.5岁,35%为女性,70%为糖尿病患者,平均低密度脂蛋白(LDL)胆固醇水平75.0 mg/dL,平均甘油三酯水平240 mg/dL,平均HDL-C水平36mg/dL,平均高敏C反应蛋白水平2.1 mg/L,12633名患者(96.6%)完成试验。接受omega-3 CA治疗患者中,785名(12.0%)出现主要终点事件,而玉米油组为795名患者(12.2%,危险比为0.99)。与接受玉米油治疗的患者(14.7%)相比,omega-3 CA组的胃肠道不良事件发生率更高(24.7%)。
 
研究认为,对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件风险。
 
原始出处
 

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-12-28 ms6000000854809298

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-25 BJying

    #Omega-3脂肪酸# #JAMA# #他汀治疗# #心血管# 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-18 weigq

    可能还需要更多试验来佐i证。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-18 Jessica

    也没有说随访时间是多长。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-18 咻凡

    对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-18 牧仔栋栋

    有帮助

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1778805, encodeId=2f131e78805ca, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 20 23:30:10 CST 2021, time=2021-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1955786, encodeId=54c71955e8616, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Tue Aug 24 15:30:10 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779181, encodeId=c13a1e7918154, content=<a href='/topic/show?id=2216130401' target=_blank style='color:#2F92EE;'>#3脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1304, encryptionId=2216130401, topicName=3脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Fri Jul 09 13:30:10 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911698, encodeId=e58a9116984f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62c35448317, createdName=ms6000000854809298, createdTime=Mon Dec 28 19:41:11 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902060, encodeId=ebf590206081, content=<a href='/topic/show?id=2766133286b' target=_blank style='color:#2F92EE;'>#Omega-3脂肪酸#</a> <a href='/topic/show?id=08af1024310' target=_blank style='color:#2F92EE;'>#JAMA#</a> <a href='/topic/show?id=73c22533930' target=_blank style='color:#2F92EE;'>#他汀治疗#</a> <a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a> 对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13328, encryptionId=2766133286b, topicName=Omega-3脂肪酸), TopicDto(id=10243, encryptionId=08af1024310, topicName=JAMA), TopicDto(id=25339, encryptionId=73c22533930, topicName=他汀治疗), TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Wed Nov 25 09:17:16 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900234, encodeId=880a90023436, content=可能还需要更多试验来佐i证。, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Wed Nov 18 17:15:04 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900146, encodeId=acc9900146a2, content=也没有说随访时间是多长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Wed Nov 18 11:39:00 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900111, encodeId=808990011168, content=对于正在接受他汀类药物治疗的心血管高危患者,在常规疗法中添加omega-3脂肪酸对主要心血管不良事件的综合结果无显著影响,研究不支持使用omega-3脂肪酸来减少高危患者的主要心血管不良事件, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b58d5402080, createdName=咻凡, createdTime=Wed Nov 18 10:10:13 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900086, encodeId=ce679000869b, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45435435877, createdName=牧仔栋栋, createdTime=Wed Nov 18 09:30:05 CST 2020, time=2020-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900032, encodeId=136c90003264, content=有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26415435528, createdName=ms7000000732175426, createdTime=Tue Nov 17 23:10:50 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-17 ms7000000732175426

    有帮助

    0

相关威廉亚洲官网

JAMA Intern Med:多吃植物蛋白更长寿!美国41万人16年随访研究

优质蛋白包括植物蛋白(例如大豆、豆类、坚果来源的蛋白),也包括某些动物蛋白(例如禽肉、鱼肉、饱和脂肪酸含量低的未加工红肉、低脂奶制品),其中植物蛋白更优,位于国际血脂专家组提出来的蛋白来源金字塔顶端。

Nat Med:1000多对双胞胎研究告诉你,人类餐后是怎么对食物进行反应的?

研究人员在英国招募了1,002对双胞胎和没有血缘关系的健康成年人参与PREDICT 1研究,并评估了临床环境和家庭中的餐后代谢反应。

Brit J Cancer:血脂与大肠癌风险

调整肥胖指标后,血脂水平与大肠癌风险无关。甘油三酸酯和载脂蛋白A潜在的位点特异性效应需要进一步研究进行证实。

JAMA:血脂管理仅仅是胆固醇和甘油三酯?

随着新兴证据的不断涌现,在血脂管理中,除了人们熟悉的胆固醇和甘油三酯,另一个指标——载脂蛋白B100(apoB)也开始受到更多重视。这是为什么呢?

LDL-C<1.4 mmol/L,且降幅要≥50%!中国医师协会ACS血脂管理临床路径专家共识

血脂异常是动脉粥样硬化最重要的危险因素之一。然而,我国急性冠脉综合征患者的血脂管理状况并不理想,达标率不足。

JCEM:超重和肥胖成人体重减轻与血脂的关系

过多的脂肪组织与脂质异常有关,可以通过减轻体重来改善。近日,内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一